First Header Logo Second Header Logo

Connection

Michael Miller to Calcium Channel Blockers

Back to Details
This is a "connection" page, showing publications Michael Miller has written about Calcium Channel Blockers.
Michael Miller
Connection Strength
0.052
Calcium Channel Blockers
  1. Mancini GB, Miller ME, Evans GW, Byington R, Furberg CD, Pitt B. Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT). Am J Cardiol. 2002 Jun 15; 89(12):1414-6.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.